Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 5, 2014, Pages 2004-2011.e1

  Bourguignon, Thierry ^a   Bouquiaux Stablo, Anne Lorraine ^a   Loardi, Claudia ^a   Mirza, Alain ^a   Candolfi, Pascal ^b   Marchand, Michel ^a   Aupart, Michel R ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b EDWARDS LIFESCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOPROSTHESIS; BLEEDING; CARDIOVASCULAR RISK; CARPENTIER EDWARDS BIOPROSTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; NEW YORK HEART ASSOCIATION CLASS; PROSTHESIS IMPLANTATION; SURGICAL MORTALITY; SURVIVAL RATE; THROMBOEMBOLISM; TREATMENT OUTCOME; VALVE DETERIORATION; AGE; AGED; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MIDDLE AGED; MITRAL VALVE; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSTHESIS; PROSTHESIS FAILURE; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; TIME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPROSTHESIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84911006763     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.02.050     Document Type: Conference Paper

References (30)

1. V.M. Walley, and W.J. Keon Patterns of failure in Ionescu-Shiley bovine pericardial bioprosthetic valves J Thorac Cardiovasc Surg 93 1987 925 933
2. E.A. Trowbridge, P.V. Lawford, C.E. Crofts, and K.M. Roberts Pericardial heterografts: why do these valves fail? J Thorac Cardiovasc Surg 95 1988 577 578
3. M. Marchand, M.R. Aupart, R. Norton, I.R. Goldsmith, C. Pelletier, and M. Pellerin Twelve-year experience with Carpentier-Edwards PERIMOUNT pericardial valve in the mitral position: a multicenter study J Heart Valve Dis 7 1998 292 298
4. M. Marchand, M.R. Aupart, R. Norton, I.R. Goldsmith, L.C. Pelletier, and M. Pellerin Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis Ann Thorac Surg 71 2001 236 239
5. L.H. Edmunds, R.E. Clarke, L.H. Cohn, G.L. Grunkemeier, D.C. Miller, and R.D. Weisel Guidelines for reporting morbidity and mortality after cardiac operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for standardizing Definitions of Prosthetic Heart Valve Morbidity Ann Thorac Surg 62 1996 932 935
6. C.W. Akins, D.C. Miller, M.I. Turina, N.T. Kouchoukos, E.H. Blackstone, and G.L. Grunkemeier Guidelines for reporting morbidity and mortality after cardiac valve interventions J Thorac Cardiovasc Surg 135 2008 732 738
7. P.H. Neville, M.R. Aupart, F.F. Diemont, A.L. Sirinelli, E.M. Lemoine, and M.A. Marchand Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience Ann Thorac Surg 66 1998 143 147
8. National Institute of Statistics and Economic Studies, Demographic Situation. Life table 2009-2011. http://www.ined.fr/en/pop-figures/france/deaths-causes-mortality/mortality-tables. Accessed March 11, 2014.
9. G.L. Grunkemeier, W.R.E. Jamieson, D.G. Miller, and A. Starr Actuarial vs. actual risk of porcine structural valve deterioration J Thorac Cardiovasc Surg 108 1994 709 718
10. S.H. Rahimtoola Choice of prosthetic heart valve in adults: an update J Am Coll Cardiol 55 2010 2413 2426
11. D.C. McGiffin, A.J. Galbraith, M.F. O'Brien, G.J. McLachlan, D.C. Naftel, and P. Adams An analysis of valve re-replacement after aortic valve replacement with biologic devices J Thorac Cardiovasc Surg 113 1997 311 318
12. W.R.E. Jamieson, L.H. Burr, R.T. Miyagishima, M.T. Janusz, G.J. Fradet, and S.V. Lichtenstein Reoperation for bioprosthetic mitral structural failure: risk assessment Circulation 108 2003 98 102
13. M. Wilbring, K. Alexiou, S.M. Tugtekin, B. Sill, P. Hammer, and T. Schmidt Transapical transcatheter valve-in-valve implantation for deteriorated mitral valve bioprostheses Ann Thorac Surg 95 2013 111 117
14. N.C. Poirier, L.C. Pelletier, M. Pellerin, and M. Carrier 15-Year experience with the Carpentier-Edwards pericardial bioprosthesis Ann Thorac Surg 66 1998 57 61
15. T. Murakami, K. Eishi, S. Nakano, J. Kobayashi, Y. Sasako, and F. Isobe Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results J Heart Valve Dis 5 1996 45 49
16. P.P. Caimmi, M. Di Summa, M. Galloni, L. Gastaldi, B. Papillo, and G.M. Actis Dato Twelve-year follow up with the Sorin Pericarbon bioprosthesis in the mitral position J Heart Valve Dis 7 1998 400 406
17. J.L. Pomar, W.R.E. Jamieson, L.C. Pelletier, A.N. Gerein, M. Castellá, and R.T. Brownlee Mitroflow pericardial bioprosthesis: clinical performance to ten years Ann Thorac Surg 60 1995 305 310
18. P.S. Myken, and O. Bech-Hansen A 20-year experience of 1712 patients with Biocor porcine bioprosthesis J Thorac Cardiovasc Surg 137 2009 76 81
19. C. Valfré, P. Ius, G. Minniti, L. Salvador, T. Bottio, and F. Cesari The fate of Hancock II porcine valve recipients 25 years after implant Eur J Cardiothorac Surg 38 2010 141 146
20. T.E. David, S. Armstrong, and Z. Sun The Hancock II bioprosthesis at 12 years Ann Thorac Surg 66 1998 95 98
21. W.R.E. Jamieson, M.A. Marchand, C.L. Pelletier, R. Norton, M. Pellerin, and T.W. Dubiel Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and PERIMOUNT pericardial bioprostheses J Thorac Cardiovasc Surg 118 1999 297 305
22. G.L. Grunkemeier, A.P. Furnary, Y. Wu, L. Wang, and A. Starr Durability of pericardial versus porcine bioprosthetic heart valves J Thorac Cardiovasc Surg 144 2012 1381 1386
23. G. Palaretti, and B. Cosmi Bleeding with anticoagulation therapy: who is at risk and how best to identify such patients Thromb Haemost 102 2009 268 278
24. K.E. Hammermeister, G.K. Sethi, W.C. Henderson, F.L. Grover, C. Oprian, and S.H. Rahimtoola Outcomes 15 years after valve replacement with a mechanical versus bioprosthetic valve: final report of the Veterans Affairs randomized trial J Am Coll Cardiol 36 2000 1152 1158
25. M.A. Borger, J. Ivanov, S. Armstrong, D. Christie-Hrybinsky, C.M. Feindel, and T.E. David Twenty-year results of the Hancock II bioprosthesis J Heart Valv Dis 15 2006 49 56
26. K. Holper, M. Wottke, T. Lewe, L. Baumer, H. Meisner, and S.U. Paek Bioprosthetic and mechanical valves in the elderly: benefits and risks Ann Thorac Surg 60 1995 443 446
27. A. Russo, F. Grigioni, J.F. Avierinos, W.K. Freeman, R. Suri, and H. Michelena Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications J Am Coll Cardiol 51 2008 1203 1211
28. S.C. Cannegieter, F.R. Rosendaal, A.R. Wintzen, F.J.M. Van der Meer, J.P. Vandenbroucke, and E. Briet Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 1995 11 17
29. D. Horstkotte, H. Schulte, W. Bircks, and B. Strauer Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10-year follow-up of patients with St. Jude Medical prostheses J Heart Valve Dis 2 1993 291 301
30. J.M. Toole, M.R. Stroud, J.M. Kratz, A.J. Crumbley III, S.M. Bradley, and F.A. Crawford Jr. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis Ann Thorac Surg 89 2010 1402 1409